logo

Bristol-Myers Squibb Co. (BMY)



Trade BMY now with
  Date
  Headline
6/15/2018 8:33:16 AM Bristol-Myers Squibb: CNDA Approves Country’s First Immuno-Oncology Agent, Opdivo (nivolumab Injection)
6/14/2018 4:33:07 PM Bristol-Myers Squibb Declares Quarterly Dividend Of $0.40, Payable Aug. 1/ Record July 6
6/14/2018 4:31:41 PM Bristol-Myers Squibb Co. (BMY) Declares Quarterly Dividend of $ 0.40, Record Date 7/6/2018
6/13/2018 6:00:49 AM Bristol-Myers Squibb To Present New Research Findings On Treatment Of Patients With Early Rheumatoid Arthritis
6/4/2018 9:11:05 AM Bristol-Myers Announces Updated Results From Phase 3 CheckMate -238 Trial Evaluating Opdivo Versus Yervoy
6/4/2018 6:59:55 AM Bristol-Myers Squibb: Opdivo Plus Chemotherapy Showed Improved Progression-Free Survival Versus Chemotherapy
6/1/2018 7:01:22 AM Bristol-Myers Squibb Reports Outcomes Data From Phase 3 CheckMate -214 Trial Of Opdivo Plus Low-Dose Yervoy
5/3/2018 8:42:25 AM EMA Validates BMY's Type II Application For Opdivo Plus Yervoy Combination For Treatment Of First-Line Metastatic NSCLC
5/2/2018 8:31:14 AM Bristol-Myers Squibb And Flatiron Health Announce Three-year Collaboration Agreement
4/27/2018 7:04:56 AM Advantagene Enters Clinical Trial Collaboration With Bristol-Myers Squibb